...
首页> 外文期刊>Systematic Reviews >Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis
【24h】

Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis

机译:在子宫内或母乳喂养期间暴露的婴儿和儿童中抗癫痫药的比较安全性:用于系统评价和网络荟萃分析的方案

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Epilepsy affects about 1% of the general population. Anti-epileptic drugs (AEDs) prevent or terminate seizures in individuals with epilepsy. Pregnant women with epilepsy may continue taking AEDs. Many of these agents cross the placenta and increase the risk of major congenital malformations, early cognitive and developmental delays, and infant mortality. We aim to evaluate the comparative safety of AEDs approved for chronic use in Canada when administered to pregnant and breastfeeding women and the effects on their infants and children through a systematic review and network meta-analysis. Methods Studies examining the effects of AEDs administered to pregnant and breastfeeding women regardless of indication (e.g., epilepsy, migraine, pain, psychiatric disorders) on their infants and children will be included. We will include randomized clinical trials (RCTs), quasi-RCTs, non-RCTs, controlled before-after, interrupted time series, cohort, registry, and case-control studies. The main literature search will be executed in MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials. We will seek unpublished literature through searches of trial protocol registries and conference abstracts. The literature search results screening, data abstraction, and risk of bias appraisal will be performed by two individuals, independently. Conflicts will be resolved through discussion. The risk of bias of experimental and quasi-experimental studies will be appraised using the Cochrane Effective Practice and Organization of Care Risk-of-Bias tool, methodological quality of observational studies will be appraised using the Newcastle-Ottawa Scale, and quality of reporting of safety outcomes will be conducted using the McMaster Quality Assessment Scale of Harms (McHarm) tool. If feasible and appropriate, we will conduct random effects meta-analysis. Network meta-analysis will be considered for outcomes that fulfill network meta-analysis assumptions. The primary outcome is major congenital malformations (overall and by specific types), while secondary outcomes include fetal loss/miscarriage, minor congenital malformations (overall and by specific types), cognitive development, psychomotor development, small for gestational age, preterm delivery, and neonatal seizures. Discussion Our systematic review will address safety concerns regarding the use of AEDs during pregnancy and breastfeeding. Our results will be useful to healthcare providers, policy-makers, and women of childbearing age who are taking anti-epileptic medications. Systematic review registration PROSPERO CRD42014008925 .
机译:背景癫痫病约占总人口的1%。抗癫痫药(AED)可预防或终止癫痫患者的癫痫发作。患有癫痫病的孕妇可以继续服用AED。这些药物中有许多穿过胎盘,增加了先天性严重畸形,早期认知和发育迟缓以及婴儿死亡率的风险。我们的目标是通过系统的回顾和网络荟萃分析,评估批准用于加拿大的孕妇和哺乳期妇女长期使用的AED的相对安全性,及其对婴儿和儿童的影响。方法包括研究对孕妇和哺乳期妇女服用AED的影响,无论其适应症如何(例如,癫痫,偏头痛,疼痛,精神疾病)。我们将包括随机临床试验(RCT),准RCT,非RCT,前后对照,中断时间序列,队列,登记和病例对照研究。主要文献检索将在MEDLINE,EMBASE和对照试验的Cochrane中央寄存器中进行。我们将通过搜索试验方案注册表和会议摘要来寻找未出版的文献。文献检索结果的筛选,数据抽象和偏倚评估的风险将由两个人分别进行。冲突将通过讨论解决。实验和准实验研究的偏倚风险将使用Cochrane有效实践和医疗保健偏见风险工具进行评估,观察性研究的方法学质量将使用纽卡斯尔-渥太华量表进行评估,安全结果将使用McMaster危害质量评估量表(McHarm)工具进行。如果可行和适当,我们将进行随机效应荟萃分析。将考虑满足网络荟萃分析假设的结果的网络荟萃分析。主要结局是主要的先天性畸形(总体和特定类型),而次要结局包括胎儿丢失/流产,轻微的先天性畸形(总体和特定类型),认知发育,精神运动发育,胎龄小,早产和新生儿惊厥。讨论我们的系统评价将解决在怀孕和母乳喂养期间使用AED的安全问题。我们的结果对于使用抗癫痫药的医疗保健提供者,决策者和育龄妇女有用。系统审查注册PROSPERO CRD42014008925。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号